Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-02

Clinical Trial Update: Alprazolam and Eating Behavior in Anorexia Nervosa

View source ↗

Summary

The clinical trial evaluating alprazolam's impact on eating behavior in individuals with anorexia nervosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Anorexia Nervosa | Status: COMPLETED